{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:08Z","timestamp":1793325668579,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.autrev.2023.103512","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T22:38:46Z","timestamp":1704062326000},"page":"103512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"L.","family":"Ondrej\u010d\u00e1kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gregov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bubov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0005","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","article-title":"Ankylosing spondylitis and bowel disease","volume":"20","author":"Rudwaleit","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103512_bb0020","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","article-title":"Long-term evolution of gut inflammation in patients with spondyloarthropathy","volume":"110","author":"De Vos","year":"1996","journal-title":"Gastroenterology."},{"key":"10.1016\/j.autrev.2023.103512_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3899\/jrheum.180135","article-title":"The role of the microbiome in gut and joint inflammation in psoriatic arthritis and Spondyloarthritis","volume":"94","author":"Gilis","year":"2018","journal-title":"J Rheumatol Suppl"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis inception cohort","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"20","key":"10.1016\/j.autrev.2023.103512_bb0035","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3748\/wjg.15.2449","article-title":"Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease","volume":"15","author":"Salvarani","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0040","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"30","key":"10.1016\/j.autrev.2023.103512_bb0045","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","article-title":"Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS","volume":"54","author":"Essers","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103512_bb0055","series-title":"Understanding the pathogenesis of spondyloarthritis biomolecules","first-page":"10","volume":"10","author":"Sharip","year":"2020"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0060","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology."},{"issue":"8","key":"10.1016\/j.autrev.2023.103512_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-023-00984-8","article-title":"Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies","volume":"19","author":"Cozzi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"18","key":"10.1016\/j.autrev.2023.103512_bb0070","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment","volume":"25","author":"Fragoulis","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.crohns.2009.11.005","article-title":"The joint-gut axis in inflammatory bowel diseases","volume":"4","author":"Brakenhoff","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"11","key":"10.1016\/j.autrev.2023.103512_bb0080","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3899\/jrheum.110070","article-title":"Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care","volume":"38","author":"Poddubnyy","year":"2011","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0085","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kez025","article-title":"Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis","volume":"58","author":"Rademacher","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103512_bb0090","doi-asserted-by":"crossref","first-page":"8630871","DOI":"10.1155\/2019\/8630871","article-title":"Biomarkers in inflammatory bowel disease-associated Spondyloarthritis: state of the art and unmet needs","volume":"2019","author":"Benfaremo","year":"2019","journal-title":"J Immunol Res"},{"issue":"14","key":"10.1016\/j.autrev.2023.103512_bb0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003102","article-title":"Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis","volume":"9","author":"Braun","year":"2023","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.autrev.2023.103512_bb0110","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/gut.17.11.906","article-title":"Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27)","volume":"17","author":"Mallas","year":"1976","journal-title":"Gut."},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0115","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/rheumatology\/kev218","article-title":"Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis","volume":"54","author":"Kenna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0120","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171503","article-title":"The role of polymorphic ERAP1 in autoinflammatory disease","volume":"38","author":"Reeves","year":"2018","journal-title":"Biosci Rep"},{"issue":"11","key":"10.1016\/j.autrev.2023.103512_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013795","article-title":"Evidence for significant overlap between common risk variants for Crohn\u2019s disease and ankylosing spondylitis","volume":"5","author":"Laukens","year":"2010","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5152\/tjg.2016.15466","article-title":"Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single Centre in Turkey","volume":"27","author":"K\u00fc\u00e7\u00fck\u015fahin","year":"2016","journal-title":"Turk J Gastroenterol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6090081","article-title":"IL-23 and Th17 disease in inflammatory arthritis","volume":"6","author":"Yago","year":"2017","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity."},{"issue":"2","key":"10.1016\/j.autrev.2023.103512_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","article-title":"Review: the interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11926-011-0198-2","article-title":"Mucosal inflammation in spondylarthritides: past, present, and future","volume":"13","author":"Van Praet","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis--beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0016-5085(03)00661-9","article-title":"Crohn\u2019s disease and the NOD2 gene: a role for paneth cells","volume":"125","author":"Lala","year":"2003","journal-title":"Gastroenterology."},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0170","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M008072200","article-title":"Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB","volume":"276","author":"Ogura","year":"2001","journal-title":"J Biol Chem"},{"issue":"5710","key":"10.1016\/j.autrev.2023.103512_bb0175","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.1104911","article-title":"Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract","volume":"307","author":"Kobayashi","year":"2005","journal-title":"Science (New York, NY)"},{"issue":"6","key":"10.1016\/j.autrev.2023.103512_bb0180","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2004.028837","article-title":"CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn\u2019s disease","volume":"64","author":"Laukens","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2023.103512_bb0185","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1521-6918(11)70006-3","article-title":"Novel development in extraintestinal manifestations and spondylarthropathy","volume":"25","author":"De Vos","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103512_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","article-title":"A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1","volume":"39","author":"Hampe","year":"2007","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0195","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.215","article-title":"Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn\u2019s disease","volume":"40","author":"McCarroll","year":"2008","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.autrev.2023.103512_bb0200","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"issue":"Suppl. 11","key":"10.1016\/j.autrev.2023.103512_bb0205","first-page":"S47","volume":"63","author":"Zochling","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.autrev.2023.103512_bb0210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/1756-185X.12779","article-title":"The ongoing quest for biomarkers in ankylosing spondylitis","volume":"18","author":"Danve","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0215","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/ard.2009.120139","article-title":"Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis","volume":"69","author":"Poddubnyy","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0220","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cgh.2006.02.003","article-title":"Diagnostic value of C-reactive protein for predicting activity level of Crohn\u2019s disease","volume":"4","author":"Chamouard","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103512_bb0225","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/IJGM.S310677","article-title":"The value of serum amyloid a in the diagnosis and management of Ankylosing Spondylitis","volume":"14","author":"Hu","year":"2021","journal-title":"Int J Gener Med"},{"key":"10.1016\/j.autrev.2023.103512_bb0230","article-title":"Serum amyloid a in inflammatory rheumatic diseases: a compendious review of a renowned biomarker","volume":"11","author":"Sori\u0107 Hosman","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0235","first-page":"621","article-title":"Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity","volume":"77","author":"Ugur","year":"2015","journal-title":"Nagoya J Med Sci"},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0240","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0245","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10067-013-2469-y","article-title":"Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results","volume":"33","author":"Gheita","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","article-title":"Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis","volume":"75","author":"Chen","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.autrev.2023.103512_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2017.01.016","article-title":"Interluekin-17A (IL17A)","volume":"614","author":"Chen","year":"2017","journal-title":"Gene."},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0260","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/annrheumdis-2020-217927","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"79","author":"Fauny","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1756-185X.14246","article-title":"The association between elevated serum interleukin-22 and the clinical diagnosis of axial spondyloarthritis: a retrospective study","volume":"25","author":"Sagiv","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103512_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631603","article-title":"IL-33 gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients","volume":"12","author":"Iwaszko","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0275","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1038\/s41598-018-25722-z","article-title":"Increase in Il-31 serum levels is associated with reduced structural damage in early axial Spondyloarthritis","volume":"8","author":"Rosine","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","article-title":"Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis","volume":"22","author":"Jarlborg","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2023.103512_bb0285","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1535370216681551","article-title":"Calprotectin in rheumatic diseases","volume":"242","author":"Ometto","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0290","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0295","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/14397595.2018.1519103","article-title":"Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment","volume":"29","author":"Hu","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","article-title":"Clinical value of fecal calprotectin","volume":"56","author":"Ricciuto","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0310","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","article-title":"Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum","volume":"47","author":"Klingberg","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103512_bb0315","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: a systematic review","volume":"18","author":"Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.autrev.2023.103512_bb0320","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3899\/jrheum.100269","article-title":"pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease","volume":"37","author":"de Vries","year":"2010","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103512_bb0325","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00042737-200209000-00013","article-title":"Evaluation of serological markers to differentiate between ulcerative colitis and Crohn\u2019s disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods","volume":"14","author":"Linskens","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103512_bb0330","doi-asserted-by":"crossref","first-page":"4029584","DOI":"10.1155\/2017\/4029584","article-title":"Gastrointestinal symptoms and elevated levels of Anti-Saccharomyces cerevisiae antibodies are associated with higher disease activity in Colombian patients with Spondyloarthritis","volume":"2017","author":"Romero-S\u00e1nchez","year":"2017","journal-title":"Int J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0335","first-page":"920","article-title":"Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Riente","year":"2004","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/40.1.15","article-title":"Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn\u2019s disease and ankylosing spondylitis","volume":"40","author":"Tiwana","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0345","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohn\u2019s disease-associated immune responses to auto- and microbial antigens","volume":"123","author":"Landers","year":"2002","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0350","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.MIB.0000218765.84087.42","article-title":"Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD","volume":"12","author":"Iltanen","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0355","first-page":"230","article-title":"Serological markers in inflammatory bowel disease: a review of their clinical utility","volume":"74","author":"Barahona-Garrido","year":"2009","journal-title":"Rev Gastroenterol Mex"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0360","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2006.02.013","article-title":"Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn\u2019s disease","volume":"130","author":"Mei","year":"2006","journal-title":"Gastroenterology."},{"issue":"12","key":"10.1016\/j.autrev.2023.103512_bb0365","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1572-0241.2004.40417.x","article-title":"Sero-reactivity to microbial components in Crohn\u2019s disease is associated with disease severity and progression, but not NOD2\/CARD15 genotype","volume":"99","author":"Arnott","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103512_bb0370","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ibd.20146","article-title":"Seroreactivity to microbial components in Crohn\u2019s disease is associated with ileal involvement, noninflammatory disease behavior and NOD2\/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients","volume":"13","author":"Papp","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0375","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ibd.20106","article-title":"Anti-flagellin (CBir1) phenotypic and genetic Crohn\u2019s disease associations","volume":"13","author":"Papadakis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103512_bb0380","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/ar2866","article-title":"Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study","volume":"11","author":"Mundwiler","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0385","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar4350","article-title":"Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study","volume":"15","author":"Wallis","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0390","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3899\/jrheum.161216","article-title":"Detection of Crohn disease in patients with Spondyloarthropathy: the SpACE capsule study","volume":"45","author":"Kopylov","year":"2018","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103512_bb0395","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2012.01.001","article-title":"The promise and pitfalls of serologic testing in inflammatory bowel disease","volume":"41","author":"Sellin","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"issue":"10","key":"10.1016\/j.autrev.2023.103512_bb0400","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1373\/49.10.1685","article-title":"YKL-40 as a marker of joint involvement in inflammatory bowel disease","volume":"49","author":"Bernardi","year":"2003","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0405","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.2008.102046","article-title":"Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints","volume":"69","author":"Uderhardt","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0410","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis","volume":"62","author":"Daoussis","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.12","article-title":"Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis","volume":"48","author":"Zhang","year":"2016","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103512_bb0420","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10067-018-4284-y","article-title":"Correlation between magnetic resonance imaging (MRI) findings and the new bone formation factor Dkk-1 in patients with spondyloarthritis","volume":"38","author":"Zhao","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0425","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3899\/jrheum.170833","article-title":"Sclerostin and Antisclerostin antibody serum levels predict the presence of axial Spondyloarthritis in patients with inflammatory bowel disease","volume":"45","author":"Luchetti","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103512_bb0430","doi-asserted-by":"crossref","first-page":"9101964","DOI":"10.1155\/2018\/9101964","article-title":"Serum Sclerostin as a possible biomarker in ankylosing spondylitis: a case-control study","volume":"2018","author":"Perrotta","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0435","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.38968","article-title":"Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression","volume":"67","author":"Syrbe","year":"2015","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"issue":"6","key":"10.1016\/j.autrev.2023.103512_bb0440","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00296-019-04301-z","article-title":"Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study","volume":"39","author":"Hulejov\u00e1","year":"2019","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0445","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15403\/jgld-3504","article-title":"Serum Visfatin as a diagnostic marker of active inflammatory bowel disease","volume":"30","author":"Saadoun","year":"2021","journal-title":"J Gastrointest Liver Diseas"},{"issue":"23","key":"10.1016\/j.autrev.2023.103512_bb0450","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/jcs.190546","article-title":"Tenascin-C at a glance","volume":"129","author":"Midwood","year":"2016","journal-title":"J Cell Sci"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0455","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10067-017-3938-5","article-title":"Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis","volume":"37","author":"Gupta","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103512_bb0460","doi-asserted-by":"crossref","first-page":"653","DOI":"10.33549\/physiolres.934414","article-title":"Elevated tenascin-C serum levels in patients with axial Spondyloarthritis","volume":"69","author":"Bubov\u00e1","year":"2020","journal-title":"Physiol Res"},{"key":"10.1016\/j.autrev.2023.103512_bb0465","doi-asserted-by":"crossref","first-page":"1475705","DOI":"10.1155\/2019\/1475705","article-title":"Tenascin-C is increased in inflammatory bowel disease and is associated with response to infliximab therapy","volume":"2019","author":"Ning","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2023.103512_bb0470","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2474-15-93","article-title":"The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases","volume":"15","author":"Sun","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"10.1016\/j.autrev.2023.103512_bb0475","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/39.12.1357","article-title":"Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not","volume":"39","author":"Ribbens","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2023.103512_bb0480","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar3857","article-title":"Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis","volume":"14","author":"Mattey","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2023.103512_bb0485","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ibd\/izz195","article-title":"Matrix metalloproteinase 3 predicts therapeutic response in inflammatory bowel disease patients treated with infliximab","volume":"26","author":"Barberio","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.autrev.2023.103512_bb0490","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1136\/annrheumdis-2013-203824","article-title":"Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2023.103512_bb0495","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1002\/art.30627","volume":"63","author":"Pedersen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0500","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2249.2003.02101.x","article-title":"High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies","volume":"132","author":"Drouart","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"6302","key":"10.1016\/j.autrev.2023.103512_bb0505","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/348600a0","article-title":"Intracellular transport of class II MHC molecules directed by invariant chain","volume":"348","author":"Lotteau","year":"1990","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.autrev.2023.103512_bb0510","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BJ20070446","article-title":"The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface","volume":"406","author":"Arneson","year":"2007","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.autrev.2023.103512_bb0515","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/annrheumdis-2012-202208","article-title":"Autoantibodies against CD74 in spondyloarthritis","volume":"73","author":"Baerlecken","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"29","key":"10.1016\/j.autrev.2023.103512_bb0520","doi-asserted-by":"crossref","first-page":"27203","DOI":"10.1074\/jbc.M104684200","article-title":"Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program","volume":"276","author":"Matza","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722300246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722300246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T05:14:25Z","timestamp":1730956465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722300246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S156899722300246X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103512","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103512"}}